As expected, in addition to activating the p53 pathway, VPRBP depletion also markedly induced PD-L1 expression levels in both native and p53-null EMT6 cells (Fig. 4a), and similar results were obtained in p53-null 4T1 mouse mammary tumor cells (Supplementary Fig. 6a). This evidence concerns the gene TP53 and breast cancer.